Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126526) titled 'Randomized controlled clinical study on the efficacy of empagliflozin in preventing and treating myocardial injury associated with hematopoietic stem cell transplantation in children' on June 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Second University Hospital, Sichuan University
Condition:
Cardiac Myocardial Injury Associated with Hematopoietic Stem Cell Transplantation in Children
Intervention:
Blank group:Blank control
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-10
Target Sample Size: Blank group:30;Intervention gro...